Management of Patients With ST-Elevation Myocardial Infarction Executive Summary

Table of Contents	Print a PDF	References	Figures & Tables
< Previous		Next >

Antman et al., Management of Patients With STEMI: Executive Summary
J Am Coll Cardiol 2004;44:671-719

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)

Developed in Collaboration With the Canadian Cardiovascular Society

Appendix 1. ACC/AHA Committee to Revise the 1999 Guidelines for Management of Acute Myocardial Infarction — Relationships With Industry

Committee Member Name	Research Grant	Speakers Bureau/ Honoraria	Stock Ownership	Consultant
Dr. Elliott M. Antman	Aventis Bayer Biosite Boehringer Mannheim Bristol-Myers Squibb British Biotech Centor Cor/Millennium Corvas Dade Genentech Lilly Merck Pfizer Sunol	None	None	Aventis
Dr. Daniel T. Anbe	None	None	None	None
Dr. Paul W. Armstrong	Boehringer Ingelheim Eli Lilly Hoffmann-LaRoche Millennium Proctor & Gamble Sanofi	Aventis Hoffman-LaRoche	Medicure, Inc.	Aventis Hoffman-LaRoche Medicure, Inc.
Dr. Eric R. Bates	Aventis Centocor Cor/Millennium Eli Lilly Genentech The Medicines Co. Merck	None	None	None
Dr. Lee A. Green	None	None	None	None
Ms. Mary Hand	None	None	None	None
Dr. Judith S. Hochman	Merck Aventis Cor/Millennium Guidant Lilly	None	None	Daichii Proctor & Gamble
Dr. Harlan M. Krumholz	None	None	None	Astra-Zeneca BMS/Sanofi CVT
Dr. Frederick G. Kushner	Aginamoto Co. Andrx Labs Atherogenics, Inc. Boehringer-Ingelheim Medtronic Novartis Rorer Schering-Plough	Bristol-Myers Squibb Merck Pfizer Reliant	Abbott Labs Baxter Guidant Medtronic Merck Pfizer	None
Dr. Gervasio A. Lamas	Astra Zeneca Bayer Centocor Bristol-Myers Squibb Guidant Lilly Medtronic Novartis Schering	None	None	None
Dr. Charles J. Mullany	Cardiogenesis	None	None	None
Dr. Joseph P. Ornato	Genentech Meridian Medical Corp. Wyeth	None	None	Bristol-Myers-Squibb Genentech HP/Agilent Medtronic Meridian Medical Corp. Philips PhysioControl/Scios Revivant Corp. Wyeth
Dr. David L. Pearle	None	GlaxoSmithKlein Novartis Pfizer	None	None
Dr. Michael A. Sloan	Abbott Labs Astra Zeneca Bristol-Myers Squibb Genentech Novo-Nordisk	Boehringer-Ingelheim Dupont Genentech Merck Nicolet-EME	None	None
Dr. Sidney C. Smith, Jr.	Merck Pfizer	Medtronic	None	None

This table represents the actual or potential relationships of committee members with industry that were reported orally at the initial writing committee meeting in January 2002 and updated in conjunction with all meetings and conference calls of the writing committee. It does not reflect any actual or potential relationships at the time of publication.

American College of Cardiology

Helping Cardiovascular Professionals Learn. Advance. Heal.

Antman et al., Management of Patients With STEMI: Executive Summary J Am Coll Cardiol 2004;44:671-719

Antman et al., Management of Patients With STEMI: Executive Summary
J Am Coll Cardiol 2004;44:671-719